Multidrug resistance in the protozoan parasite Entamoeba histolytica

Parasitology International

Volumn 51, Issue 4, 2002, Pages 353-359

  Orozco, E ^a   Lopez C ^b   Gomez C ^b   Perez D G ^b   Marchat, L ^b   Banuelos C ^a   Delgadillo, D M ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Entamoeba histolytica; Multidrug resistance; Protozoan parasite

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; GENE PRODUCT; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PROTOZOAL PROTEIN; TRANSCRIPTION FACTOR;

AMEBIASIS; ARTICLE; CHLORIDE CURRENT; CROSS RESISTANCE; ENTAMOEBA HISTOLYTICA; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; MAMMAL CELL; MULTIDRUG RESISTANCE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTOZOAL GENETICS; REGULATORY MECHANISM; RNA STABILITY; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

ANIMALS; CLONE CELLS; DRUG RESISTANCE, MULTIPLE; ENTAMOEBA HISTOLYTICA; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; P-GLYCOPROTEIN; PROTOZOAN PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION, GENETIC;

ENTAMOEBA; ENTAMOEBA HISTOLYTICA; MAMMALIA; PROTOZOA;

EID: 0036888209     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(02)00041-7     Document Type: Article

References (37)

1. Borst P., Ouellette M. New mechanisms of drug resistance in parasitic protozoa. Ann Rev Microbiol. 49:1995;427-460.
2. World Health Organization . Weekly Epidemiol Rec. 72:1997;97-100.
3. Martínez-Palomo A. Amibiasis. 1989;Editorial Médica Panamericana, México.
4. Biagi F. Amoebiasis. Antibiot Chemother. 30:1981;20-27.
5. Samarawickrema N.A., Brown D.M., Upcroft J.A., Thammapalerd N., Upcroft P. Involvement of superoxide dismutase and piruvate ferredoxin oxidorreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. Antimicrob Agents Chemother. 40:1997;833-840.
6. Orozco E., Hernández F., Rodríguez M.A. Isolation and characterization of Entamoeba histolytica mutants resistant to emetine. Mol Biochem Parasitol. 15:1985;49-59.
7. Burchard G.D., Mirelman D. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing non-pathogenic zymodemes. Exp Parasitol. 66:1988;231-242.
8. Hanna R.M., Dahniya M., Badr S.S., El-Betagy A. Percutaneous catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health. 5:2000;578-581.
9. Ayala P., Samuelson J., Wirth D., Orozco E. Entamoeba histolytica: physiology of multidrug resistance. Exp Parasitol. 71:1990;169-175.
10. Samuelson J.C., Burke A., Courval J.M. Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers. Antimicrob Agents Chemother. 36:1992;2392-2397.
11. Dano K. Active outward transport of daunomycin in resistant Erlich ascites tumor cells. Biochem Biophys Acta. 323:1973;466-483.
12. Loo T.W., Clarke D.M. Molecular dissection of the human multidrug resistance P-glycoprotein. Biochem Cell Biol. 77:1999;11-23.
13. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57:1989;921-930.
14. Ouellette M., Fase-Fowler F., Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9:1990;1027-1033.
15. Johnson P.J., Schuck B.L., Delgadillo M.G. Analysis of a single-domain P-glycoprotein-like gene in the early-diverging protist Trichomonas vaginalis. Mol Biochem Parasitol. 66:1994;127-137.
16. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated drug resistance. Ann Rev Biochem. 58:1989;137-171.
17. Jones P.M., George A.M. A new structural model for P-glycoprotein. J Membr Biol. 166:1998;133-147.
18. Chang G., Roth C.B. Structure of MsbA from E. coli: a homologue of the multidrug resistance ATP binding cassette (ABC) transporters. Science. 293:2001;1793-1800.
19. Descoteaux S., Ayala P., Orozco E., Samuelson J. Primary sequences of two P-glycoprotein genes of Entamoeba histolytica. Mol Biochem Parasitol. 54:1992;201-212.
20. Descoteaux S., Ayala P., Orozco E., Samuelson J. Increase in mRNA of multiple EhPgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene. 164:1995;179-184.
21. Orozco E., Pérez D.G., Gómez M.C., Ayala P. Multidrug resistance in Entamoeba histolytica. Parasitol Today. 11:1995;473-475.
22. Gómez C., Pérez D.G., López-Bayghen E., Orozco E. Transcriptional analysis of the EhPgp1 promoter of Entamoeba histolytica multidrug resistant mutants. J Biol Chem. 273:1998;7277-7284.
23. Pérez D.G., Gómez C., López-Bayghen E., Tannich E., Orozco E. Transcriptional analysis of the EhPgp5 promoter of Entamoeba histolytica multidrug resistant mutants. J Biol Chem. 273:1998;7285-7292.
24. Purdy J.E., Pho L.T., Mann B.J., Petri W.A. Jr. Upstream regulatory elements controlling expression of the Entamoeba histolytica lectin. Mol Biochem Parasitol. 78:1996;91-103.
25. Orozco E., Gharaibeh R., Riverón A.M., et al. A novel cytoplasmic structure containing DNA networks in Entamoeba histolytica trophozoites. Mol Gen Genet. 254:1997;250-257.
26. Shen D.W., Fojo A., Chin J.E. Human multidrug-resistance cell lines. Increased mdr1 expression can precede gene amplification. Science. 232:1986;643-645.
27. López C., Gómez C., Pérez D.G., Flores E., Orozco E. Putative amplification of the EhPgp genes in Entamoeba histolytica emetine-resistant mutants. Arch Med Res. 28:1997;S66-S68.
28. Beverley S.M. Gene amplification in Leishmania. Ann Rev Microbiol. 45:1991;417-444.
29. Lee H., Bradley G., Ling V. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth Diff. 354:1995;347-354.
30. Lee H., Bradley G., Ling V. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo. J Cell Physiol. 177:1998;1-12.
31. López C., Marchat L., Luna-Arias J.P., Orozco E. An initial characterization of the 3′ untranslated region of the EhPgp5 mRNA in Entamoeba histolytica. Arch Med Res. 31:2000;S282-S284.
32. Johnstone R.W., Ruefli A.A., Smyth M.J. Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci. 25:2000;1-6.
33. Valverde M.A., Díaz M., Sepúlveda F.V., Gill D.R., Hyde S.C., Higgins C.F. Volume-regulated chloride channels associated with the human multidrug resistance P-glycoprotein. Nature. 355:1992;830-833.
34. Gill D.R., Hyde S.C., Higgins C.F., Valverde M.A., Mintening G.M., Sepúlveda F.V. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell. 71:1992;23-32.
35. Rasola A., Galietta L.J.V., Gruener D.C., Romeo G. Volume-sensitive chloride currents in four epithelial cell lines are not directly correlated to the expression of the MDR-1 gene. J Biol Chem. 269:1994;1432-1436.
36. Delgadillo D.M., Pérez D.G., Gómez C., Ponce A., Paz F., Bañuelos C., Mendoza L., López C., Orozco E. The Entamoeba histolytica EhPGP5 (MDR-like) protein induces swelling in transfected trophozoites and alters chloride-dependent currents in Xenopus laevis oocytes. Microbiol Drug Resist. 8:2002;15-26.
37. - currents are activated by cell swelling but do not contribute to cell volume regulation. Cancer Res. 54:1994;618-622.